Collaborative deployment of digital enablers such as artificial intelligence, IoT, and blockchain aid in shift toward value-based care SANTA CLARA, California, Oct. 9, 2018 /PRNewswire/ -- The ...
Medindia on MSN
Weight-Loss Without Needles: Obesity Care Enters a New Era With FDA’s First GLP-1 Pill
FDA approves oral semaglutide, the first GLP-1 weight-loss pill, offering effective obesity treatment with cardiovascular protection—no injections needed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback